Access
This article is part of Nature's premium content.
Published online 2 November 2009 | Nature 462, 22 (2009) | doi:10.1038/462022a
News
California stem-cell grants awarded
First major round of research targeted at therapies takes off.
The starting gun has fired for 14 research teams, based in California, who now have four years to make good on the therapeutic promise of stem cells.
On 28 October, the California Institute for Regenerative Medicine (CIRM) committed US$230 million to teams of basic and clinical researchers aiming to move experimental stem-cell treatments into an investigational new-drug filing with the US Food and Drug Administration.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
I have chronic dystonia and dyskinesia caused by the neuroleptic medication risperidal (risperidone) and which is also exacerbated and worsened by the fact I'm on zyrexa. My psychiatrist has told me I either have to take a risperidone derivative or zyprexa for my psychotic condition. I've been having psychosis problems since several years ago, when I was first put on medication. I am looking forward to stem cell research and treatments somehow correcting my physical and mental problems, so I can stop taking the harmful and dangerous medications. They even cause people to die, and they are definitely worsending my physical and mental conditions, not making them better.